Compound ID | 1230
Zidebactam + Cefepime
Synonym(s): WCK 5222 | WCK-5222 | WCK5222
Class: Beta-lactam + beta-lactamase inhibitor
| Agent Type: | Semisynthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Beta-lactamase inhibitor |
| Target Pathogen: | Active against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii; indicated for complicated urinary tract infections hospital-acquired bacterial pneumonia/ ventilator-associated bacterial pneumonia, complicated intraabdominal infections, and bacteraemia |
| Combined with other compounds: | Yes |
| Institute where first reported: | Wockhardt Ltd. |
| Highest development stage: | Phase 3 (NCT04979806); New Drug Application has been accepted |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.